Mrs Lynn M Schafer, MA | |
One Sylvester Ave., Berrien Springs, MI 49103 | |
(269) 471-8858 | |
Not Available |
Full Name | Mrs Lynn M Schafer |
---|---|
Gender | Female |
Speciality | Audiologist |
Location | One Sylvester Ave., Berrien Springs, Michigan |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508266941 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
231H00000X | Audiologist | 1601000365 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Lynn M Schafer, MA One Sylvester Ave, Berrien Springs, MI 49103 Ph: (269) 471-8858 | Mrs Lynn M Schafer, MA One Sylvester Ave., Berrien Springs, MI 49103 Ph: (269) 471-8858 |
News Archive
On November 24, 2021, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron (B.1.1.529) variant was first reported to the World Health Organization (WHO) from South Africa.
Levels of high density lipoprotein (HDL) may not accurately represent cardiovascular risk in older women, according to a new study.
Elderly patients with limited-stage small cell lung cancer showed similar survival and toxicity compared to their younger counterparts when treated with concurrent chemo-radiotherapy. Concurrent chemo-radiotherapy should be a treatment option for fit patients aged 70 years or older.
Halozyme Therapeutics, Inc. today announced the completion of its root cause investigation regarding HYLENEX manufacturing and has identified a corrective action plan and regulatory strategy to reintroduce HYLENEX to the market. Halozyme and Baxter are finalizing the materials for a meeting with the U.S. Food and Drug Administration to seek concurrence with the reintroduction strategy.
Each year, more than 100,000 patients in the U.S. undergo implantation of a new implantable cardioverter defibrillator (ICD) for heart rhythm abnormalities. This number constitutes a 20-fold increase over the last 15 years. Current medical guidelines advocate discussion of end of life care of these medical devices, including deactivation, but many patients may not understand their options.
› Verified 2 days ago